AI drug discovery company Atomwise raises $51M series A

Artificial intelligence-based drug discovery company Atomwise Inc. (San Francisco, Calif.) raised $45 million in a series A round on March 7 led by new investors Monsanto Growth Ventures and B Capital Group and seed investor DCVC. Also participating were existing investors Y Combinator, Khosla Ventures and DFJ and new investors Baidu Ventures, Tencent and Dolby Family Ventures.

Atomwise has raised more than $51 million to date...